Axcelis Technologies Inc (ACLS) Expected to Post Earnings of $0.17 Per Share
Analysts expect Axcelis Technologies Inc (NASDAQ:ACLS) to announce earnings per share (EPS) of $0.17 for the current quarter, Zacks reports. Three analysts have issued estimates for Axcelis Technologies’ earnings, with the lowest EPS estimate coming in at $0.17 and the highest estimate coming in at $0.18. Axcelis Technologies reported earnings of $0.38 per share during the same quarter last year, which suggests a negative year over year growth rate of 55.3%. The firm is scheduled to announce its next quarterly earnings report on Thursday, November 1st.
On average, analysts expect that Axcelis Technologies will report full-year earnings of $1.33 per share for the current financial year, with EPS estimates ranging from $1.33 to $1.34. For the next fiscal year, analysts anticipate that the business will post earnings of $1.85 per share, with EPS estimates ranging from $1.65 to $2.05. Zacks’ earnings per share averages are a mean average based on a survey of sell-side research firms that that provide coverage for Axcelis Technologies.
Axcelis Technologies (NASDAQ:ACLS) last released its earnings results on Thursday, August 2nd. The semiconductor company reported $0.43 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.35 by $0.08. Axcelis Technologies had a return on equity of 16.84% and a net margin of 28.57%. The firm had revenue of $119.30 million during the quarter, compared to analysts’ expectations of $116.33 million. During the same period in the previous year, the firm posted $0.42 EPS. Axcelis Technologies’s revenue for the quarter was up 16.1% on a year-over-year basis.
Several institutional investors have recently bought and sold shares of ACLS. Mount Yale Investment Advisors LLC purchased a new stake in shares of Axcelis Technologies in the 1st quarter valued at about $143,000. Piedmont Investment Advisors LLC purchased a new stake in shares of Axcelis Technologies in the 2nd quarter valued at about $148,000. Bank of Montreal Can purchased a new stake in shares of Axcelis Technologies in the 2nd quarter valued at about $161,000. Metropolitan Life Insurance Co. NY lifted its holdings in shares of Axcelis Technologies by 362.2% in the 2nd quarter. Metropolitan Life Insurance Co. NY now owns 10,363 shares of the semiconductor company’s stock valued at $205,000 after purchasing an additional 8,121 shares during the last quarter. Finally, LSV Asset Management purchased a new stake in shares of Axcelis Technologies in the 2nd quarter valued at about $209,000. 84.59% of the stock is owned by institutional investors and hedge funds.
ACLS traded down $0.30 on Friday, hitting $19.85. 3,511 shares of the company were exchanged, compared to its average volume of 290,343. Axcelis Technologies has a twelve month low of $18.35 and a twelve month high of $37.05. The stock has a market capitalization of $655.20 million, a price-to-earnings ratio of 13.55 and a beta of 0.85.
Axcelis Technologies Company Profile
Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips worldwide. The company offers a line of high energy, high current, and medium current implanters for various application requirements. It also provides dry strip equipment, curing systems, and thermal processing systems.
Featured Story: Asset Allocation
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Axcelis Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axcelis Technologies and related companies with MarketBeat.com's FREE daily email newsletter.